Latest Clinical trials biotechnology articles and news on biotech industry leaders, emerging biotech companies in Spain

Young people, pregnant women and drivers, the main groups in which cannabis can have significant harmful effects

by Fundació Clínic per a la Recerca Biomèdica

6 months ago
Cannabis

Researchers from the Hospital Clínic-IDIBAPS have taken part in an international study that shows that cannabis and cannabinoids can improve some medical conditions.

A possible new combination of treatments to combat cancer

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

6 months ago
IKKα, protein BRD4, JAK/STAT, LIF protein

This involves combining different existing treatments to target cancer cells on three fronts and stop their progression. The study is published in the EMBO Journal.

Analyzed the resistance to chemotherapy of acute myeloid leukemia

by Universidad Autónoma de Madrid

6 months ago
acute myeloid leukemia

The Experimental Hematology group belonging to the Jiménez Díaz Foundation Health Research Institute and the Autonomous University of Madrid (UAM) have summarized, in a series of recent bibliographi...

The PragmaTIL project aims to optimize cell therapy with TILs in patients with melanoma, lung cancer, and cervical cancer

by VHIO

6 months ago
Adoptive cell therapy with TILs, interleukin-2 (IL-2)

The main objective of the project is to optimize the treatment with tumor-infiltrating lymphocyte adoptive cell therapy (TIL-ACT) of patients with melanoma, lung cancer, or cervical cancer. and substa...

The world’s first collection of brain metastasis living samples will help treat each patient with the most effective therapy for them

by CNIO - Centro Nacional de Investigaciones Oncológicas

6 months ago
brain metastasis, organotypic cultures, RENACER

On live samples researchers can study the way cancer cells respond to drugs. This paves the way to create individual avatars for each patient on which to test out possible therapies before applying th...

Mineralys Therapeutics Presents New Post-Hoc Analysis from Target-HTN Phase 2 Trial of Lorundrostat in Late-Breaking Poster Session at ASN Kidney Week 2023 Meeting

by Ysios Capital

6 months ago
Mineralys Therapeutics, Target-HTN

Endotype identification from Target-HTN may represent a shift towards targeted, precision-directed therapy for hypertension management in future treatment paradigm

New treatment in trial for previously treated small cell lung cancer shows promising results

by CNIO - Centro Nacional de Investigaciones Oncológicas

6 months ago
tarlatamab, small cell lung cancer

In a phase II trial the drug tarlatamab "showed antitumor activity with durable objective responses and promising survival outcomes", researchers write in `The New England Journal of Medicine´.

Peptomyc is awarded €5 million from the Horizon Europe EIC Accelerator Program to conduct a Phase 1b clinical trial with OMO-103 in patients and scale up its manufacturing process

by Peptomyc

6 months ago
Peptomyc, Horizon Europe, European Innovation Council (EIC) Accelerator Program, metastatic pancreatic cancer

The biotech company Peptomyc S.L. announced today that it has been awarded €5 million blended financing from the Horizon Europe, European Innovation Council (EIC) Accelerator Program. The grant will...

Palobiofarma Receives Rare Pediatric Disease Designation from the U.S. FDA for PBF-999 for the Treatment of Prader-Willi Syndrome

by Palobiofarma

6 months ago
Palobiofarma, Rare Pediatric Disease (RPD) Designation, FDA, Prader-Willi Syndrome

Palobiofarma has announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) Designation for the company’s phosphodiesterase 10 (PDE-10) inhibitor, PBF-999, f...

ORYZON announces Last Patient Last Visit in its Phase IIb PORTICO study for Borderline Personality Disorder (BPD)

by Oryzon Genomics

6 months ago
vafidemstat, ORYZON, Borderline Personality Disorder (BPD)

Oryzon Genomics, S.A. today announced Last Patient Last Visit in its ongoing Phase IIb PORTICO trial, investigating vafidemstat’s efficacy in Borderline Personality Disorder (BPD). Multiple primary ...

Manina Medtech, Vall d’Hebron spin-off, closes an investment round to develop a medical device to increase the success of In Vitro Fertilization

by Vall d’Hebron

6 months ago
vitro fertilization (IVF), SEEDCHRONY, Manina Medtech

After carrying out a first feasibility trial in collaboration with the Assisted Reproduction Section of the Vall d'Hebron Hospital, Manina Medtech is moving towards a pilot trial in IVF patients.

El nuevo objetivo de la investigación del cáncer es erradicar la metástasis antes de que aparezca

by CNIO - Centro Nacional de Investigaciones Oncológicas

6 months ago
CNIO Frontiers Meeting ‘Metástasis’, metástasis

Ensayos presentados en el CNIO van a la caza y captura de las escasísimas células cancerígenas que pueden quedar durmientes en el organismo después de tratado el cáncer, y que son capaces de desp...